Showing results (31-40 of 252) with videos related to
Sort By:
Pageof 26
Cancer Control : Journal of the Moffitt Cancer Center|October 9, 2012
Advances in the management of myelofibrosisRami S Komrokji, Srdan Verstovsek, Eric Padron, et al.Academic Pathology|February 4, 2020
Educational Case: Invasive Ductal Carcinoma of the BreastAshley Rose Scholl, Melina B FlanaganClinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Prognostic factors and risk models in myelodysplastic syndromesRami S Komrokji, Eric Padron, Jeffrey E Lancet, et al.Best Practice & Research. Clinical Haematology|February 11, 2014
Deletion 5q MDS: molecular and therapeutic implicationsRami S Komrokji, Eric Padron, Benjamin L Ebert, et al.Current Opinion in Hematology|January 10, 2015
Current state of prognostication and risk stratification in myelodysplastic syndromesAmer M Zeidan, Steven D Gore, Eric Padron, et al.JCO Clinical Cancer Informatics|April 18, 2019
Leveraging Single-Cell RNA Sequencing Experiments to Model Intratumor HeterogeneityMeghan C Ferrall-Fairbanks, Markus Ball, Eric Padron, et al.Leukemia|June 27, 2021
Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemiaAline Renneville, Mrinal M Patnaik, Onyee Chan, et al.Clinical Lymphoma, Myeloma & Leukemia|February 1, 2022
Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)Onyee Chan, Najla Al Ali, David Sallman, et al.CBE Life Sciences Education|October 22, 2024
Breaking Stereotypes: How Undergraduates' Life Experiences of Scientists Shape their Scopes of PossibilityAshley Rose Acosta-Parra, Dax Ovid, Brie TrippJournal of Technical Writing and Communication|April 2, 2026
Synthetic Genres: Expert Genres, Non-Specialist Audiences, and Misinformation in the Artificial Intelligence AgeBrad Mehlenbacher, Ana Patricia Balbon, Ashley Rose MehlenbacherPageof 26